OPTIMIERTE VERBINDUNGEN

European patent · EP3728289 · In force

Register entry

Publication number
EP3728289
Application number
EP18890144
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 21, 2018
Published
Oct 28, 2020
Granted
Sep 10, 2025
Protection ends at the latest
Dec 20, 2038
Next annual fee due
Dec 31, 2026
IPC classes
A61K 38/10 (2006.01)
A61K 39/39 (2006.01)
A61P 31/16 (2006.01)
A61P 11/00 (2006.01)
A61K 47/60 (2017.01)
A61K 47/54 (2017.01)
A61P 31/00 (2006.01)
A61K 39/00 (2006.01)
C07C 317/48 (2006.01)
C07C 323/60 (2006.01)
C07K 5/062 (2006.01)
Priority
AU 2017905128 21.12.2017
AU 2018901056 29.03.2018
AU 2018903597 25.09.2018
PCT application
PCT/AU2018/051397 21.12.2018
PCT publication
WO2019/119067 27.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 22, 2026

    Change

    Published in Swissreg on 22.07.2026

  2. Jan 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.12.2025 → 31.12.2026

    Published in Swissreg on 01.01.2026

  3. Sep 10, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 10.09.2025

Parties

Holder

Axelia Oncology Pty Ltd

Level 9 31 Queen Street, Melbourne VIC 3000, AU

Inventor

JACKSON, David

Melbourne, Victoria 3000, AU

HOLMES, Ian

Melbourne, Victoria 3000, AU

ZENG, Weiguang

Melbourne, Victoria 3000, AU

DEMAISON, Christophe

Melbourne, Victoria 3000, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.